Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

FG 001

Next Previous
Drug Profile

FG 001

Alternative Names: FG-001; FG001 sodium; ICG-Glu-Glu-AE105

Latest Information Update: 02 Sep 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator FluoGuide
  • Class Diagnostic agents; Diagnostic conjugates; Imaging agents; Small molecules
  • Mechanism of Action Diagnostic imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Glioma
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Glioblastoma; Glioma; Head and neck cancer; Meningioma; Non-small cell lung cancer; Squamous cell cancer
  • No development reported Pancreatic cancer

Most Recent Events

  • 25 Aug 2026 Phase-II clinical trials in Glioma (Diagnosis) in USA (IV) (NCT07609472)
  • 01 Jul 2026 FluoGuide plans a first patient enrollment in a phase II registration trial for Glioma in the US in July 2026
  • 29 Jun 2026 Updated efficacy and safety data from a phase II FG001-CT-005 trial released by FluoGuide

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top